[1]
Sushaniba, K. 2017. Rationale for stem cell therapy for type 2 diabetes mellitus. Biomedical Research and Therapy. 4, 02 (Feb. 2017), 1166-1170. DOI:https://doi.org/10.15419/bmrat.v4i02.152.